<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39341402</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.</ArticleTitle><Pagination><StartPage>106292</StartPage><MedlinePgn>106292</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2024.106292</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(24)00226-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Our aim was to estimate the risk of pneumonia, admission to intensive care unit (ICU) or death in individuals ≥65 years old admitted to hospital with RSV, compared to influenza or COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included hospitalised patients from Severe Acute Respiratory Infection Surveillance in Spain between 2021-2024, aged ≥65 years, laboratory confirmed for RSV, influenza or SARS-CoV-2. Using a binomial regression with logarithmic link, we estimated the relative risk (RR) of pneumonia, ICU admission and in-hospital mortality, in patients with RSV compared to influenza or SARS-CoV-2, adjusting for age, sex, season and comorbidities. We stratified the estimates by vaccination status for influenza or SARS-CoV2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among patients unvaccinated for influenza or SARS-CoV-2, those with RSV had similar or lower risk of pneumonia [vs. influenza: RR= 0.91 (95% Confidence Interval: 0.72-1.16); vs. SARS-CoV-2: 0.81 (0.67-0.98)], ICU admission [vs. influenza: 0.93 (0.41-2.08); vs. SARS-CoV-2: 1.10 (0.61-1.99)] and mortality [vs. influenza: 0.64 (0.32-1.28); vs. SARS-CoV-2: 0.56 (0.30-1.04)]. Among the vaccinated, results were largely similar except for a higher risk of ICU admission with RSV [vs. influenza: 2.13(1.16-3.89); vs. SARS-CoV-2: 1.83 (1.02-3.28)] CONCLUSIONS: RSV presented similar or lower intrinsic severity than influenza or SARS-CoV2. Among vaccinated patients, RSV was associated to higher ICU-admission, suggesting the potential for preventive RSV vaccination.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vega-Piris</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain. Electronic address: lorena.vega@isciii.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carretero</LastName><ForeName>Silvia Galindo</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayordomo</LastName><ForeName>José Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>General University Hospital Consortium of Valencia, Valencian Community, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarzuelo</LastName><ForeName>Mercedes Belén Rumayor</ForeName><Initials>MBR</Initials><AffiliationInfo><Affiliation>Directorate General of Public Health, Regional Ministry of Health of Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Río</LastName><ForeName>Virginia Álvarez</ForeName><Initials>VÁ</Initials><AffiliationInfo><Affiliation>Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla y León, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García</LastName><ForeName>Virtudes Gallardo</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Occupational Health and Surveillance Service, Directorate General of Public Health and Pharmaceutical Regulation, Ministry of Health and Consumer of Andalucía, Andalucía, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vázquez</LastName><ForeName>Miriam García</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Epidemiological Surveillance, Directorate General of Public Health, Department of Health, Government of Aragón, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodríguez</LastName><ForeName>María Del Carmen García</ForeName><Initials>MDCG</Initials><AffiliationInfo><Affiliation>Epidemiological Surveillance, Directorate General of Public Health, Extremadura Health Service, Mérida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basile</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Public Health Agency of Catalonia, Department of Health, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González-Coviella</LastName><ForeName>Nieves López</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Epidemiological Surveillance Unit of the Directorate General of Public Health of the Canary Health Service, Canary Islands, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boada</LastName><ForeName>Maria Isabel Barranco</ForeName><Initials>MIB</Initials><AffiliationInfo><Affiliation>Epidemiology Service, Health Department, General Directorate of Public Health and Addictions, Murcia Region, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez-Martínez</LastName><ForeName>Olaia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Epidemiology Service, Directorate General of Public Health, Ministry of Health, Regional Government of Galicia, Santiago, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azevedo</LastName><ForeName>Ana Lameiras</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Public Health Directorate General, Health Department, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>Carmen Quiñones</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>Epidemiology and Health Prevention Service, Directorate General of Public Health, Consumer and Care of La Rioja, Logroño, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duran</LastName><ForeName>Jaume Giménez</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Epidemiology Service, Directorate General of Public Health, Balearic Islands, Spain; Health Research Institute of the Balearic Islands (IdISBa), Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibáñez</LastName><ForeName>Ana Fernández</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Epidemiological Surveillance Service, Public Health Asturias, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>María Victoria García</ForeName><Initials>MVG</Initials><AffiliationInfo><Affiliation>Epidemiology Service Technician, General Directorate of Public Health, Ministry of Health of Castilla La Mancha, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marín</LastName><ForeName>Violeta Ramos</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Epidemiological Surveillance, Council of Health, Ceuta, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castrillejo</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiological Surveillance, Ministry of Social Policies and Public Health of Melilla, Directorate General of Public Health, Melilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raymundo</LastName><ForeName>Luis Javier Viloria</ForeName><Initials>LJV</Initials><AffiliationInfo><Affiliation>Epidemiological Surveillance Section, General Directorate of Public Health, Ministry of Health of Cantabria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrauri</LastName><ForeName>Amparo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain; CIBER on Epidemiology and Public Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monge</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain; CIBER on Infectious Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SARI Sentinel Surveillance Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="N">Respiratory Syncytial Virus, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU admission</Keyword><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword><Keyword MajorTopicYN="N">SARS-CoV2</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory infection</Keyword><Keyword MajorTopicYN="N">Syncytial respiratory virus</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39341402</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2024.106292</ArticleId><ArticleId IdType="pii">S0163-4453(24)00226-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle>